2Esteve J, Benhamou E, Raymond L. Statistical Methods in Cancer Research Volume IV, Descriptive Epidemiology [ M ].IARC Scientific Publications, No 128, Lyon, 1994.
3Coleman MP, Esteve J, Damiecki P, et al. Trends in Cancer Incidence and Mortality [ M ]. IARC Scientific Publications,1993, 121.
4Herrinton LJ, Stanford ]L, Schwartz SM, et al. Ovarian cancer incidence among Asian migrants to the United States and their descendents[J]. ] Nail Cancer Inst, 1994, 86(1):1336.
5Titus-Ernstoff L, Perez K, Cramer DW, et al. Menstrual and reproductive factors in relation to ovarian cancer risk[J ]. Br J Cancer, 2001, 84(5): 714.
6Zhang M, Yang ZY, Binns CW, et al. Diet and ovarian cancer risk: a ease-control study in China[J]. Br J Cancer, 2002, 86 (5) : 712.
7Gao YT, Shu XO, Dai Q, et al. Association of menstrual and reproductive factors with breast cancer risk; results from the Shanghm breast cancer study[J]. Int J Cancer, 2000, 87:295.
8Percy CL, Miller BA, Gloeelder Ries LA. EHeet of changes in cancer classification and the accuracy of cancer death certificates ontrends in cancer mortality[J]. Ann NY Acad Sci, 1990,609: 687.
9Shu XO, Brinton LA, Zheng W, et al. Relation of obesity and body fat distribution to endometrial cancer in Shanghai, China [J]. Cancer Res,1992, 52:3865.
10Shu XO, Brinton LA, Zheng W, et al. A population-based casecontrol study of endometrial cancer in Shanghai, China[J]. Int J Cancer, 1991, 49:38.
1Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the compa- rative C (T) method [ J ]. Nat Protoc ,2008,3 ( 6 ) : 1101-1108.
2Call KM, Glaser T, ho CY, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms'tumor locus [J]. Cell, 1990,60(3) : 509-520.
3Qi xw, Zhang F, Yang XH,et al. High Wilms'tumor 1 mRNA expres- sion correlates with basal-like and ERBB2 molecular subtypes and poor prognosis of breast cancer[ J]. Oncol Rep, 2012,28 (4) : 1231-1236.
4Takahashi H, Okamoto M, Shimodaira S, et al. Impact of dendritic cell vaccines pulsed with Wilms'tumor-1 peptide antigen on the survival of patients with advanced non-small cell lung cancers [ J ]. Eur J Cancer, 2013,49 (4) :852-859.
5Tyler EM, Jungbluth AA, O'Reilly RJ, et al. WTl-specific T-cell re- sponses in high-risk multiple myeloma patients undergoing allogeneic T ceil-depleted hematopoietic stem cell transplantation and donor lympho- cyte infusions[J]. Blood,2013,121 (2) :308-317.
6Ritchie MF, Yue C, Zhou Y,et al. Wilms tumor suppressor 1 (WT1) and early growth response 1 ( EGR1 ) are regulators of STIM1 expression [ J ]. J Biol Chem,2010,285 (14) : 10591-10596.
7Hu Q, Gao F, Tian W, et al. Wtl ablation and Igt2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation [ J ]. J Clin Invest,2011,121 ( 1 ) :174-183.
8A1-Salam S, Balalaa N, Faour I, et al. HIF-lc, VEGF and WT-1 are protagonists in bilateral primary angiosarcoma of breast: a case report and review of literature[ J ]. Int J Clin Exp Pathol, 2012,5 ( 3 ) :247- 253.
9Duhig EE, Kalpakos L, Yang IA, et al. Mesothelial markers in high-grade breast carcinoma[ J ]. Histopathology ,2011,59 ( 5 ) :957-964.
10Kramarzova K, Stuchly J, Willasch A, et al. Real-time PCR quantification of major Wilms'tumor gene 1 ( WT1 ) isoforms in acute myeloid leuke- mia, their characteristic expression patterns and possible functional con- sequences [ J ]. Leukemia,2012,26 (9) : 2086-2095.
